ASLAN Pharmaceuticals Ltd (ASLN) Stock Cash Flow
NASDAQ:ASLN - Nasdaq - US04522R2004 - ADR - Currency: USD
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -51.28M | -31.59M | -16.97M | -46.66M | -42.17M | |||
| Depreciation Amortization | 331.75K | 280.00K | 300.00K | 440.00K | 250.00K | |||
| Change In Working Capital | 6.91M | -4.12M | -100.00K | -3.78M | 1.45M | |||
| Interest Paid | 2.34M | 0.00 | 0.00 | 40.00K | 0.00 | |||
| Taxes Paid | 105.00K | 0.00 | 0.00 | 410.00K | 10.00K | |||
| Other non cash items | 5.64M | 1.43M | 1.72M | 24.19M | 1.01M | |||
| OPERATING CASH FLOW | -38.41M | -34.00M | -15.05M | -25.80M | -39.47M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -27.11K | -40.00K | -10.00K | 0.00 | -80.00K | |||
| Other Investing Activity | 441.81K | 10.00K | 10.00K | 10.00K | -23.01M | |||
| INVESTING CASH FLOW | 414.70K | -30.00K | 0.00 | 10.00K | -23.09M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 4.72M | 11.84M | -240.00K | 3.01M | 4.06M | |||
| Stock Issued/Repurchased | 0.00 | 102.60M | 7.64M | 14.76M | 42.23M | |||
| Other Financing Activity | 0.00 | -4.58M | -230.00K | 1.33M | -5.39M | |||
| FINANCING CASH FLOW | 4.72M | 109.87M | 7.17M | 19.09M | 40.90M | |||
| Exchange Rate Effect | N/A | N/A | N/A | -6.30M | 49.30M | |||
| CHANGE IN CASH | -33.27M | 75.84M | -7.88M | -6.70M | -21.66M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -38.41M | -34.00M | -15.05M | -25.80M | -39.47M | |||
| Capital Expenditure | -27.11K | -40.00K | -10.00K | 0.00 | -80.00K | |||
| FREE CASH FLOW | -38.43M | -34.04M | -15.06M | -25.80M | -39.55M | |||
All data in USD